Exercise capacity impairment in COPD patients with comorbidities

被引:6
|
作者
Da Silva, G. P. F. [1 ,3 ]
Pessoa Morano, M. T. A. [2 ]
De Matos Cavalcante, A. G. [1 ]
De Andrade, N. M. [1 ]
De Francesco Daher, E. [1 ]
Pereira, E. D. B. [1 ]
机构
[1] Univ Fed Ceara UFC, Fortaleza, Ceara, Brazil
[2] Hosp Messejana Dr Carlos Alberto Studart Gomes, Fortaleza, Ceara, Brazil
[3] Univ Fortaleza UNIFOR, Fortaleza, Ceara, Brazil
关键词
Exercise capacity; Health status; COPD; Comorbidity; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; ARTERIAL STIFFNESS; EMPHYSEMA; MORTALITY; ANXIETY; IMPACT; INTERVENTION;
D O I
10.1016/j.rppnen.2015.04.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Comorbidities are common in COPD and have been associated with reduced health status, increased health care utilization, all-cause hospitalization, and mortality. There is a scarcity of data on the relationship between comorbidities and functional capacity. Objective: to evaluate the impact of comorbidities on functional capacity of COPD patients. Methods: a cross-sectional study was conducted at two teaching hospitals in Fortaleza, Brazil. The functional capacity was assessed by spirometry and the 6-min walking test (6MWT). The health status was assessed by the St. George's respiratory questionnaire (SGRQ) and the COPD assessment test (CAT). The sample was stratified as having "none", "one" and "two or three'' comorbidities groups. One-way ANOVA was used to compare means of the three groups and a multiple linear regression was run to predict the impact of comorbidities on 6MWT. Results: Comorbidities (hypertension, coronary disease and diabetes) were found in 54% of the studied patients. The mean age of the 79 patients was 67 +/- 8 years and 55% were male. CAT scores increased from "no comorbidity" (17.9 +/- 7.7) to "one comorbidity" (22.8 +/- 6.8) and "two or three comorbidities" groups (24.2 +/- 10.2). A post hoc test showed a significant difference in the "no comorbidity" compared to the "two or three comorbidities" groups (p = 0.01). The distance walked by the patients decreased from "no comorbidity" (386.1 +/- 83.2 m) to "one comorbidity" (350 +/- 98 m) and "two or three comorbidities" groups (312.6 +/- 91 m). A post hoc test showed significant difference in the "no comorbidity" compared to "two or three comorbidities" groups (p = 0.007). Numbers of comorbidities were independently associated with the 6 MWT adjusting for age, severity of COPD and CAT scores. Conclusion: in the studied sample, the presence of comorbidities contributed to impair exercise capacity in patients with COPD. (C) 2014 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 50 条
  • [21] Mind-body exercise for patients with stable COPD on lung function and exercise capacity: a systematic review and meta-analysis of RCTs
    Zhu, Yutong
    Zhang, Zhihao
    Du, Zhihao
    Zhai, Feng
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [22] Illness perceptions predict exercise capacity and psychological well-being after pulmonary rehabilitation in COPD patients
    Zoeckler, Natalie
    Kenn, Klaus
    Kuehl, Kerstin
    Stenzel, Nikola
    Rief, Winfried
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2014, 76 (02) : 146 - 151
  • [23] Exercise Capacity and Ventilatory Response During Exercise in COPD Patients With and Without β Blockade
    Wilawan Thirapatarapong
    Hilary F. Armstrong
    Matthew N. Bartels
    Lung, 2013, 191 : 531 - 536
  • [24] The effects of anxiety and depression symptoms on treatment adherence in COPD patients
    Turan, Onur
    Yemez, Beyazit
    Itil, Oya
    PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT, 2014, 15 (03) : 244 - 251
  • [25] Mechanisms of improvement in exercise capacity using a rollator in patients with COPD
    Probst, VS
    Troosters, T
    Coosemans, I
    Spruit, MA
    Pitta, FD
    Decramer, M
    Gosselink, R
    CHEST, 2004, 126 (04) : 1102 - 1107
  • [26] A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD
    Liesker, JJW
    Wijkstra, PJ
    Ten Hacken, NHT
    Koëter, GH
    Postma, DS
    Kerstjens, HAM
    CHEST, 2002, 121 (02) : 597 - 608
  • [27] ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD
    Watz, Henrik
    Troosters, Thierry
    Beeh, Kai M.
    Garcia-Aymerich, Judith
    Paggiaro, Pierluigi
    Molins, Eduard
    Notari, Massimo
    Zapata, Antonio
    Jarreta, Diana
    Gil, Esther Garcia
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 2545 - 2558
  • [28] Exercise capacity and lobar hyperinflation in patients with COPD
    Leemans, Glenn
    Ides, Kris
    Van Holsbeke, Cedric
    Vos, Wim
    De Backer, Jan
    De Backer, Wilfried
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [29] Evaluation of Markers of Inflammation and Oxidative Stress in COPD Patients with or without Cardiovascular Comorbidities
    Kazmierczak, Marcin
    Ciebiada, Maciej
    Pekala-Wojciechowska, Anna
    Pawlowski, Maciej
    Nielepkowicz-Gozdzinska, Agnieszka
    Antczak, Adam
    HEART LUNG AND CIRCULATION, 2015, 24 (08) : 817 - 823
  • [30] Can static hyperinflation predict exercise capacity in COPD?
    Ladeira, I.
    Oliveira, P.
    Gomes, J.
    Lima, R.
    Guimaraes, M.
    PULMONOLOGY, 2023, 29 : S44 - S53